TB-500
Thymosin Beta-4 (TB-500) is a naturally occurring peptide present in almost all human and animal cells. It plays a crucial role in tissue repair and regeneration.
Mechanism of Action
TB-500 promotes cell migration and differentiation, regulates actin (a cell-building protein), and reduces inflammation. It supports the formation of new blood vessels and wound healing.
Dosage Overview
Dose Range
2 mg – 2.5 mg
Route
subcutaneous
Frequency
Weekly
Cycle Length
4–8 weeks
Reconstitution
Typical Dosage (Research)
Research protocols typically use 2-2.5mg twice weekly during the loading phase, followed by maintenance dosing of 2mg every 2 weeks.
Administered via subcutaneous or intramuscular injection. Some protocols suggest injection near injury sites.
Considerations for Men & Women
Women: Thymosin beta-4 fragment for tissue repair and wound healing. No established sex-specific differences in healing properties. Avoid during pregnancy due to growth factor activity and insufficient safety data.
Men: Same healing and anti-inflammatory profile. Often used alongside BPC-157. No sex-specific dose adjustments.
Individual responses vary. These notes reflect general trends from research literature and are not medical advice.
Quick Calculator
Concentration: 2.5 mg/ml
Volume to inject: 0.80 ml
Syringe units (U-100): 80.0 units
Pre-filled with TB-500 defaults. Adjust values as needed.
Side Effects & Risks
May cause temporary fatigue, headache, or localized irritation at injection sites.
Theoretical concerns about promoting growth of existing cancers due to angiogenic properties. Not approved for human use.
Who Uses TB-500
Athletes with muscle, tendon, or ligament injuries, individuals seeking enhanced recovery.
Frequently Asked Questions
Similar Peptides
View All Alternatives →IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified version of IGF-1 with extended half-life and enhanced potency. The modifications prevent binding to IGF binding proteins, increasing bioavailability.
Mod GRF 1-29 (Modified GRF 1-29, also called CJC-1295 without DAC or Tetrasubstituted GRF 1-29) is a modified growth hormone-releasing hormone analog with improved stability over natural GHRH.
Human Growth Hormone (somatropin) is a 191-amino acid protein identical to naturally produced GH. FDA-approved for growth hormone deficiency, Turner syndrome, and other conditions. Widely used off-label for anti-aging and performance.
MGF (Mechano Growth Factor) is a splice variant of IGF-1 that is produced locally in muscle tissue in response to mechanical stress. The non-PEGylated form has a very short half-life.
PEG-MGF (PEGylated Mechano Growth Factor) is a variant of IGF-1 that is produced in response to muscle damage. PEGylation extends its half-life from minutes to several hours, making it practical for use.